POLE2 and glioblastoma: Interestingly, the addition of proteasome inhibitor MG-132 (20 μM) partially eliminated the effect of POLE2 or AURKA knockdown on FOXM1 protein stability in GBM cells (Fig. 5C, D), indicating the involvement of proteasome in POLE2-induced regulation of FOXM1.